weight regain after stopping glp-1 agonists Trajectory of the body drug discontinuation in the treatment of anti-obesity medications | BMC Medicine Many people regain weight after
Description
Depression of insulin release by anti-GIP serum after oral glucose in rats
Eighty-three percent of the violative or potentially problematic GLP-1 drug ads weve identified and reported were being shown in jurisdictions where advertisements for prescription medicines are not allowed., while 15% of reported ads were offering GLP-1 drug products without a prescription

In the SCALE study, liraglutide, administered daily at a dose of 0.63.0 mg, was associated with a body weight loss 5.6 kg greater than placebo [45]

Hypoglycemia following the use of glucagon-like peptide-1 receptor agonists: A real-world analysis of post-marketing surveillance data
N Engl J Med (2015) 373:224757
